Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 217

2.

Diversity of epidermal growth factor receptor-mediated activation of downstream molecules in human lung carcinomas.

Suzuki S, Igarashi S, Hanawa M, Matsubara H, Ooi A, Dobashi Y.

Mod Pathol. 2006 Jul;19(7):986-98. Epub 2006 Apr 28.

3.
4.

Activation of the AKT and STAT3 pathways and prolonged survival by a mutant EGFR in human lung cancer cells.

Akca H, Tani M, Hishida T, Matsumoto S, Yokota J.

Lung Cancer. 2006 Oct;54(1):25-33. Epub 2006 Jul 26.

PMID:
16872715
5.

Activation of Stat3 by receptor tyrosine kinases and cytokines regulates survival in human non-small cell carcinoma cells.

Song L, Turkson J, Karras JG, Jove R, Haura EB.

Oncogene. 2003 Jul 3;22(27):4150-65.

PMID:
12833138
6.

Epidermal growth factor receptor activation in prostate cancer by three novel missense mutations.

Cai CQ, Peng Y, Buckley MT, Wei J, Chen F, Liebes L, Gerald WL, Pincus MR, Osman I, Lee P.

Oncogene. 2008 May 15;27(22):3201-10. doi: 10.1038/sj.onc.1210983. Epub 2008 Jan 14.

PMID:
18193092
7.

Activated epidermal growth factor receptor-Stat-3 signaling promotes tumor survival in vivo in non-small cell lung cancer.

Haura EB, Zheng Z, Song L, Cantor A, Bepler G.

Clin Cancer Res. 2005 Dec 1;11(23):8288-94.

8.

Functional analysis of epidermal growth factor receptor (EGFR) mutations and potential implications for EGFR targeted therapy.

Kancha RK, von Bubnoff N, Peschel C, Duyster J.

Clin Cancer Res. 2009 Jan 15;15(2):460-7. doi: 10.1158/1078-0432.CCR-08-1757.

9.

The role of constitutively active signal transducer and activator of transcription 3 in ovarian tumorigenesis and prognosis.

Rosen DG, Mercado-Uribe I, Yang G, Bast RC Jr, Amin HM, Lai R, Liu J.

Cancer. 2006 Dec 1;107(11):2730-40.

10.

Cyclin D1 is transcriptionally regulated by and required for transformation by activated signal transducer and activator of transcription 3.

Leslie K, Lang C, Devgan G, Azare J, Berishaj M, Gerald W, Kim YB, Paz K, Darnell JE, Albanese C, Sakamaki T, Pestell R, Bromberg J.

Cancer Res. 2006 Mar 1;66(5):2544-52.

13.

Cyclooxygenase-2-dependent activation of signal transducer and activator of transcription 3 by interleukin-6 in non-small cell lung cancer.

Dalwadi H, Krysan K, Heuze-Vourc'h N, Dohadwala M, Elashoff D, Sharma S, Cacalano N, Lichtenstein A, Dubinett S.

Clin Cancer Res. 2005 Nov 1;11(21):7674-82.

14.

Impact of EGFR mutation analysis in non-small cell lung cancer.

Yamamoto H, Toyooka S, Mitsudomi T.

Lung Cancer. 2009 Mar;63(3):315-21. doi: 10.1016/j.lungcan.2008.06.021. Epub 2008 Aug 29. Review.

PMID:
18760859
15.

Antitumor activity of a dual epidermal growth factor receptor and ErbB2 kinase inhibitor MP-412 (AV-412) in mouse xenograft models.

Suzuki T, Fujii A, Ohya J, Nakamura H, Fujita F, Koike M, Fujita M.

Cancer Sci. 2009 Aug;100(8):1526-31. doi: 10.1111/j.1349-7006.2009.01197.x. Epub 2009 May 13.

16.

c-Src associates with ErbB2 through an interaction between catalytic domains and confers enhanced transforming potential.

Marcotte R, Zhou L, Kim H, Roskelly CD, Muller WJ.

Mol Cell Biol. 2009 Nov;29(21):5858-71. doi: 10.1128/MCB.01731-08. Epub 2009 Aug 24.

17.

[Detection of epidermal growth factor receptor mutations in non-small cell lung cancer by real-time PCR using TaqMan-MGB probes].

Zhou CC, Zhou SW, Pan H, Su B, Gao ZQ.

Zhonghua Zhong Liu Za Zhi. 2007 Feb;29(2):119-23. Chinese.

PMID:
17645848
18.

Detection of oncogenic mutations in the EGFR gene in lung adenocarcinoma with differential sensitivity to EGFR tyrosine kinase inhibitors.

Thomas RK, Greulich H, Yuza Y, Lee JC, Tengs T, Feng W, Chen TH, Nickerson E, Simons J, Egholm M, Rothberg JM, Sellers WR, Meyerson ML.

Cold Spring Harb Symp Quant Biol. 2005;70:73-81.

PMID:
16869740
19.

Inhibition of Stat3 activation and tumor growth suppression of non-small cell lung cancer by G-quartet oligonucleotides.

Weerasinghe P, Garcia GE, Zhu Q, Yuan P, Feng L, Mao L, Jing N.

Int J Oncol. 2007 Jul;31(1):129-36.

PMID:
17549413
20.

Influence of epidermal growth factor receptor (EGFR) gene mutations on the expression of EGFR, phosphoryl-Akt, and phosphoryl-MAPK, and on the prognosis of patients with non-small cell lung cancer.

Sonobe M, Nakagawa M, Takenaka K, Katakura H, Adachi M, Yanagihara K, Otake Y, Wada H, Tanaka F.

J Surg Oncol. 2007 Jan 1;95(1):63-9.

PMID:
17192868

Supplemental Content

Support Center